HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of armepavine against hepatic fibrosis induced by thioacetamide in rats.

Abstract
The aim of this study was to investigate if armepavine (Arm, C₁₉H₂₃O₃N) could exert inhibitory effects against hepatic fibrosis in rats. A cell line of rat hepatic stellate cells (HSC-T6) was stimulated with tumour necrosis factor-α (TNF-α) to evaluate the inhibitory effects of Arm. Rats were injected with thioacetamide (TAA; 300 mg/kg, intraperitoneally) thrice a week for 4 weeks to induce hepatic fibrosis, with Arm (3 or 10 mg/kg) given by gavage twice a day. Liver sections were taken for western blotting, fibrosis scoring and immunofluorescence staining. Arm (1-10 µm) concentration-dependently attenuated TNF-α-stimulated: (i) protein expressions of α-smooth muscle actin (α-SMA), collagen type I and angiopoietin-1; (ii) H₂O₂ production; and (iii) NF-κB, JunD and C/EBPß (cytidine-cytidine-adenosine-adenosine-thymidine (CCAAT)/enhancer binding protein-ß (EBPß)) nuclear translocations in HSC-T6 cells. In vivo Arm treatment significantly reduced plasma aspartate transaminase and alanine transaminase levels, hepatic α-SMA expression and collagen contents, and fibrosis scores of TAA-injected rats. Moreover, Arm treatment decreased α-SMA- and NF-κB-positive cells in immunohistochemical staining, and mRNA expression levels of IL-6, TGF-ß1, TIMP-1, col1α2, iNOS and ICAM-1 genes, but up-regulated the metallothionein gene in the livers of TAA-injected rats. Our results indicated that Arm exerted both in vitro and in vivo antifibrotic effects in rats, with inhibition of NF-κB, JunD and C/EBPß pathways.
AuthorsTing-Chun Weng, Chien-Chang Shen, Yung-Tsung Chiu, Yun-Lian Lin, Yi-Tsau Huang
JournalPhytotherapy research : PTR (Phytother Res) Vol. 26 Issue 3 Pg. 344-53 (Mar 2012) ISSN: 1099-1573 [Electronic] England
PMID21717514 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 John Wiley & Sons, Ltd.
Chemical References
  • Actins
  • Angiopoietin-1
  • Angpt1 protein, rat
  • Benzylisoquinolines
  • CCAAT-Enhancer-Binding Protein-beta
  • Collagen Type I
  • Cytokines
  • NF-kappa B
  • Transcription Factors
  • smooth muscle actin, rat
  • Thioacetamide
  • Metallothionein
  • Hydrogen Peroxide
  • Aspartate Aminotransferases
  • Alanine Transaminase
  • armepavine
Topics
  • Actins (genetics, metabolism)
  • Active Transport, Cell Nucleus
  • Alanine Transaminase (blood)
  • Angiopoietin-1 (genetics, metabolism)
  • Animals
  • Aspartate Aminotransferases (blood)
  • Benzylisoquinolines (administration & dosage, therapeutic use)
  • Blotting, Western
  • CCAAT-Enhancer-Binding Protein-beta (genetics, metabolism)
  • Collagen Type I (metabolism)
  • Cytokines (genetics, metabolism)
  • Dose-Response Relationship, Drug
  • Fluorescent Antibody Technique
  • Hepatic Stellate Cells (cytology, drug effects, metabolism)
  • Hydrogen Peroxide (metabolism)
  • Liver Cirrhosis (chemically induced, drug therapy, pathology)
  • Male
  • Metallothionein (genetics, metabolism)
  • NF-kappa B (metabolism)
  • Phytotherapy
  • Rats
  • Rats, Sprague-Dawley
  • Thioacetamide (administration & dosage, adverse effects)
  • Transcription Factors (genetics, metabolism)
  • Transcription, Genetic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: